What is Lirio?
Lirio operates as a sophisticated personalization engine for digital health, enabling organizations to craft hyper-personalized health experiences. The platform integrates behavioral science and artificial intelligence to automate individual engagement, utilizing the first Large Behavior Model specifically designed for healthcare. This allows for the delivery of tailored communications that resonate with unique healthcare journeys. Lirio's primary clientele includes health systems and payers, aiming to enhance patient and member engagement, address care gaps, and ultimately improve health outcomes while optimizing costs. The company's approach is geared towards fostering sustained engagement and tackling health equity challenges, guiding individuals toward more effective healthcare solutions.
How much funding has Lirio raised?
Lirio has raised a total of $1.9M across 2 funding rounds:
Debt
$350K
Debt
$1.6M
Debt (2020): $350K with participation from PPP
Debt (2026): $1.6M, investors not publicly disclosed
Key Investors in Lirio
PPP
Public-Private Partnership
What's next for Lirio?
With the recent infusion of major strategic capital, Lirio is poised for accelerated growth and market penetration. The company's focus on leveraging AI and behavioral science for personalized digital health experiences aligns with the increasing demand for tailored patient engagement solutions. Future developments are likely to center on expanding the capabilities of its Large Behavior Model, enhancing its platform's integration with existing health systems and payer infrastructures, and potentially exploring new therapeutic areas or demographic segments. This strategic investment signals confidence in Lirio's model and its capacity to drive significant improvements in health outcomes and cost management within the healthcare industry.
See full Lirio company page
